ASKA Pharmaceutical Holdings Co., Ltd.

Greenhouse gas emissions & sustainability report data

📊 Latest report period: 2023🗂️ Report periods on file: 2023, 2022, 2020-04-01 to 2021-03-31

In its 2023 reporting, ASKA Pharmaceutical Holdings Co., Ltd. disclosed greenhouse gas emissions of 9.0K tCO2e/year. By scope: Scope 1: 6.1K tCO2e/year; Scope 2: 2.9K tCO2e/year. Figures are as stated in the company's own report and may use different boundaries, units or methods (for example market-based vs location-based Scope 2), so compare with care.

💨
GHG Emissions
9.0K tCO2e/year
2023
⚡
Renewable Energy
100% at Shonan Research Center; partial at Iwaki Factory and Head Office
of total energy
💧
Water Usage
170.6K m3/year
2023
♻️
Waste
185.0 tons/year
2023
⚙️
Energy Use
11.8M kWh/year (equivalent to 5694 kl of crude oil)
2023

📊 Emissions by Scope (2023)

ScopeWhat it coversReported value
Scope 1Direct emissions from sources the company owns or controls (fuel combustion, company vehicles, process and fugitive emissions).6.1K tCO2e/year
Scope 2Indirect emissions from purchased electricity, steam, heat and cooling.2.9K tCO2e/year

New to scopes? Read Scope 1, 2 and 3 emissions explained and market-based vs location-based Scope 2.

📈 Emissions by Report Period

Report periodHeadline emissions figure reported
20239.0K tCO2e/year
202210.8K t-CO₂ (FY2022)
2020-04-01 to 2021-03-3113.2K t-CO2 (FY2020)

Each row is the headline figure extracted from a different report; scope coverage and methodology can change between years.

✅ Reported Environmental Achievements

🎯 Climate & Sustainability Targets

📅 Medium-term

  • Reduce CO2 emissions by 46% by FY2030 compared to FY2013.

🔭 Long-term

  • Achieve carbon neutrality by 2050.

🌱 ESG Focus Areas

Climate ChangeEnvironmental ManagementResource ConservationWaste ReductionChemical Substance ManagementBiodiversityGreen Procurement

⚠️ Challenges & Risks +

  • Risk of unexpected pandemics and drug price reductions.
  • Risk of rising raw material prices due to climate change.
  • Increased stakeholder concerns due to delays in climate change action.
  • Risk of increased operating expenses due to climate change.
  • Risk of supply chain disruptions due to extreme weather events.

📋 Report Information

Reporting Period: 2023
Frameworks: TCFD